Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ:INBS)

1.460 -0.040 (-2.65%)
Streaming Delayed Price Updated: 2:42 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Intelligent Bio Solutions Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4
Intelligent Bio forecasts 16% revenue growth for Q4 2025 and strengthens FDA filing with new data as it expands global reach and system capabilities. 
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level
Intelligent Bio strengthens its FDA 510(k) submission with new data, cybersecurity tests, and advanced fingerprint sweat analysis technology. 
Via Benzinga
EXCLUSIVE: Intelligent Bio Targets Global Market With Distribution Pact For Sweat-Based Drug Detection Patch
Intelligent Bio expands global reach with SMARTOX deal to distribute its sweat-based drug detection patch across markets outside the U.S. and Canada. 
Via Benzinga
EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout
Intelligent Bio Solutions expands into environmental services as Managed Waste Service rolls out its drug testing system across New South Wales sites. 
Via Benzinga
Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6
Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, utilizing its fingerprint sweat-based testing technology. 
Via Stocktwits
Looking Into Intelligent Bio Solutions's Recent Short Interest
 
Via Benzinga
Peering Into Intelligent Bio Solutions's Recent Short Interest
 
Via Benzinga
Peering Into Intelligent Bio Solutions's Recent Short Interest
 
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing
Intelligent Bio grows U.S. forensic market presence via SMARTOX, with 7,000+ tests run and FDA clearance underway for wider market entry. 
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%
Intelligent Bio Solutions reported a Q3 loss of 44 cents per share with a 20% revenue rise from Q2 and 91% year-over-year gross profit growth. 
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology
Intelligent Bio Solutions (INBS) received a U.S. patent for its fingerprint drug screening technology, expanding its intellectual property portfolio. 
Via Benzinga
Topics Intellectual Property
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch
Intelligent Bio Solutions awaits FDA clearance for its fingerprint drug test, aiming for a 2025 U.S. launch and expanding its presence in the multi-billion market. 
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Which stocks are moving after the closing bell on Wednesday?
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales
Intelligent Bio Solutions reports rising sales and profit margins, driven by recurring revenue from cartridge sales and global expansion through key partnerships. 
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites
Quantum Traffic Management adopts INBS' Intelligent Fingerprinting Drug Testing Solution to improve efficiency and safety, with plans to expand in US. 
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market
Intelligent Bio Solutions collaborates with IVY Diagnostics to enhance drug screening adoption in Europe and the Middle East, targeting key regions. 
Via Benzinga
Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
 
Via Benzinga
Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
 
Via Benzinga
What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?
Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The company, specializing in non-invasive testing, advances clinical trials and... 
Via Benzinga
US Stocks Higher; Dow Surges Over 200 Points
 
Via Benzinga
Topics Stocks
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
INBS Stock Earnings: Intelligent Bio Solutions Beats EPS, Misses Revenue for Q3 2024
INBS stock results show that Intelligent Bio Solutions beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024. 
Via InvestorPlace
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions. 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.